Charles L Edelstein MD
Professor, Medicine, University of Colorado School of Medicine
Join to View Full Profile
12401 E 17th AveAurora, CO 80045
Phone+1 720-848-0000
Fax+1 720-848-6802
Dr. Edelstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cape Town Faculty of MedicineClass of 1979
Certifications & Licensure
CO State Medical License 1997 - 2027
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 2 citationsOverview of ADPKD in Pregnancy.Ruth E Campbell, Charles L Edelstein, Michel Chonchol
Kidney International Reports. 2025-04-01 - 2 citationsBardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin.Lauren E Thompson, Stacey M Tuey, Paola Garcia Gonzalez, Carly S Chesterman, Courtney D McGinnis
AAPS Open. 2025-01-01 - mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney.Daniel J Atwood, Zhibin He, Makoto Miyazaki, Katharina Hopp, Alkesh Jani
Frontiers in Immunology. 2025-01-01
Journal Articles
- Milestones in Transplantation Kidney Transplantation Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycy...C L Edelstein, S Davis, A Wiseman, L Chan, ScienceDirect
Press Mentions
XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)December 8th, 2022- XORTX Announces New Clinical Advisory Board MemberAugust 31st, 2021
- XORTX Announces New Clinical Advisory Board MemberAugust 31st, 2021
Grant Support
- mTORC1/2 Signaling in the Heart in Autosomal Dominant Polycystic Kidney Disease (ADPKD)VA EASTERN COLORADO HEALTH CARE SYSTEM2018–2026
- Mammalian Target Of Rapamycin (MTOR) Signaling In Polycystic Kidney Disease (PKD)National Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Caspase-1 Signaling In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Caspase-1 And IL-18 In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Role Of Caspases In Ischemic Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
